Aoxing Pharmaceutical(OTC) AOXG

Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer primarily operating within the People's Republic of China. The company focuses on the research, development, production, and distribution of pharmaceutical products, particularly in narcotics, pain management, and addiction treatments.

Products and Services

• Zhongtong'an: Herbal capsule for oral and dental discomfort
• Yiqi Qiangshen Granule: Herbal preparation for invigorating qi and improving blood flow
• Tilidine hydrochloride: Synthetic narcotic analgesic for pain relief

Growth Outlook

• Pipeline includes Oxycodone and Acetaminophen tablets for pain management
• Buprenorphine/Naloxone tablet completed Phase II trials for opioid dependence
• Tilidine/Naloxone compound capsule in Phase II trials for pain treatment

Financial Highlights

• Recent quarterly revenue of 11,295, showing recovery from previous lows
• Net income of 1,947 in the latest quarter, indicating positive operational performance
• Cash at end of the latest quarter increased to 24,813, reflecting improved liquidity

Aoxing Pharmaceutical Company, Inc. has established a strong foothold in the pharmaceutical industry, particularly in the realm of pain management and addiction treatment. The company's diverse product portfolio, including both established and developing products, positions it well for future growth. Recent financial performance indicates a recovery trajectory, with a notable increase in quarterly revenue and net income. The ongoing development of promising products in the pipeline further enhances the company's growth potential. Investors may find Aoxing Pharmaceutical Company, Inc. an intriguing opportunity within the healthcare sector, particularly given its focus on critical therapeutic areas.